This inventor holds 2 USPTO granted patents. Top assignees: Eliza nor Biopharmaceuticals, Inc., Other. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2001
Title: Ferenc J Sztaricskai: Innovator in Therapeutic Derivatives
Introduction
Ferenc J Sztaricskai is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of therapeutic derivatives of diphosphonates. With a total of 2 patents, his work has the potential to impact various medical treatments.
Latest Patents
Sztaricskai's latest patents include innovative compounds that are designed to treat underlying disease states. One of his patents focuses on therapeutic derivatives of diphosphonates, which are prepared by reacting a 2,2-bis-(disubstituted-phosphoryl)-ethylsulfanyl-acetic acid compound with a pharmaceutically active chemical entity. This invention aims to provide effective treatments for various conditions, including the use of non-pharmaceutical entities such as pesticides and insecticides. Another patent involves novel chemotherapeutic agents that target infectious diseases, such as periodontal disease and urinary tract infections, by combining diphosphonate compounds with therapeutic agents.
Career Highlights
Throughout his career, Sztaricskai has worked with various organizations, including Eliza Nor Biopharmaceuticals, Inc. His expertise in the field has allowed him to contribute to the advancement of medical treatments through his innovative research and development efforts.
Collaborations
Sztaricskai has collaborated with notable individuals in his field, including Pal Herczegh and John F Hartmann. These partnerships have likely enhanced his research and contributed to the success of his inventions.
Conclusion
Ferenc J Sztaricskai is a distinguished inventor whose work in therapeutic derivatives has the potential to revolutionize treatments for infectious diseases. His contributions to biopharmaceuticals reflect a commitment to innovation and improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile